| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Senseonics Holdings, Inc. | Chief Financial Officer | Common Stock | 697K | $390K | $0.56 | May 26, 2022 | Direct |
| Vistagen Therapeutics, Inc. | Chief Financial Officer | Common Stock (Right to Buy) | 150K | Dec 1, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| VTGN | Vistagen Therapeutics, Inc. | Dec 1, 2025 | 1 | $0 | 4 | Dec 4, 2025 | Chief Financial Officer |
| VTGN | Vistagen Therapeutics, Inc. | Dec 1, 2025 | 0 | $0 | 3 | Dec 4, 2025 | Chief Financial Officer |
| SENS | Senseonics Holdings, Inc. | May 26, 2022 | 2 | $0 | 4 | May 31, 2022 | Chief Financial Officer |
| SENS | Senseonics Holdings, Inc. | May 16, 2022 | 1 | -$8.87K | 4 | May 18, 2022 | Chief Financial Officer |
| SENS | Senseonics Holdings, Inc. | Feb 10, 2022 | 2 | -$179K | 4 | Feb 14, 2022 | Chief Financial Officer |
| SENS | Senseonics Holdings, Inc. | Nov 15, 2021 | 1 | -$29.8K | 4 | Nov 18, 2021 | Chief Financial Officer |
| SENS | Senseonics Holdings, Inc. | Jun 15, 2021 | 1 | -$29K | 4 | Jun 16, 2021 | Chief Financial Officer |
| SENS | Senseonics Holdings, Inc. | May 25, 2021 | 1 | $0 | 4 | May 27, 2021 | Chief Financial Officer |